Know Cancer

or
forgot password

Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer


N/A
18 Years
N/A
Open (Enrolling)
Both
Esophageal Cancer

Thank you

Trial Information

Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer


Inclusion Criteria:



- Age 18 or older

- Diagnosis of esophageal cancer, stages I-IIIC, with no prior esophageal resection.
Neoadjuvant therapy given prior to presentation at MSKCC will be accepted.

- Anticipated to undergo surgical resection (Ivor Lewis, Trans Hiatal,
thoracoabdominal, or McKeown procedure) of esophageal cancer either by open or
minimally invasive methods

- Chest and abdomen CT scan

- Ability to speak read and write English.

Exclusion Criteria:

- Inability to give informed consent

- Patients requiring a laryngectomy or colon interposition as part of their surgical
resection.

- Patients with scleroderma.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

short-term pain

Outcome Description:

Pain intensity (average of the four pain severity items) measured by BPI at Post-op Days 1 and 3, after epidural removal, at first post-operative clinic visit, at 4 months

Outcome Time Frame:

4 months

Safety Issue:

No

Principal Investigator

Inderpal Sarkaria, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

12-003

NCT ID:

NCT01558648

Start Date:

March 2012

Completion Date:

March 2015

Related Keywords:

  • Esophageal Cancer
  • Minimally Invasive Esophagectomy
  • Open Esophagectomy
  • Quality of Life
  • 12-003
  • Esophageal Diseases
  • Esophageal Neoplasms

Name

Location

Memorial Sloan Kettering Cancer CenterNew York, New York  10021